Major trial aims to extend life for women with advanced ovarian cancer

NCT ID NCT03602859

Ongoing Disease control Sponsor: Tesaro, Inc. Source: ClinicalTrials.gov ↗

Summary

This large, late-stage study is testing whether adding two newer drugs (dostarlimab and niraparib) to standard chemotherapy works better than standard care alone for women newly diagnosed with advanced ovarian cancer. The main goal is to see if the new combination can keep the cancer from growing for a longer period of time. The study involves 1400 participants and compares the new approach to the current standard treatment.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

GSK Investigational Site

Anchorage, Alaska, 99508, United States
GSK Investigational Site

Phoenix, Arizona, 85016, United States
GSK Investigational Site

Tucson, Arizona, 85711, United States
GSK Investigational Site

Los Angeles, California, 90027, United States
GSK Investigational Site

Los Angeles, California, 90048, United States
GSK Investigational Site

Newport Beach, California, 92663, United States
GSK Investigational Site

Farmington, Connecticut, 06030, United States
GSK Investigational Site

Hartford, Connecticut, 06102, United States
GSK Investigational Site

Gainesville, Florida, 32608, United States
GSK Investigational Site

Jacksonville, Florida, 32256, United States
GSK Investigational Site

Geneva, Illinois, 60555, United States
GSK Investigational Site

Warrenville, Illinois, 60555, United States
GSK Investigational Site

Zion, Illinois, 60099, United States
GSK Investigational Site

Covington, Louisiana, 70433, United States
GSK Investigational Site

New Orleans, Louisiana, 70121, United States
GSK Investigational Site

Shreveport, Louisiana, 71103, United States
GSK Investigational Site

Scarborough, Maine, 04074, United States
GSK Investigational Site

Baltimore, Maryland, 21201, United States
GSK Investigational Site

Silver Spring, Maryland, 20910, United States
GSK Investigational Site

Boston, Massachusetts, 02215, United States
GSK Investigational Site

Springfield, Massachusetts, 01199, United States
GSK Investigational Site

Worcester, Massachusetts, 01605, United States
GSK Investigational Site

Minneapolis, Minnesota, 55404, United States
GSK Investigational Site

Minneapolis, Minnesota, 55455, United States
GSK Investigational Site

Billings, Montana, 59101, United States
GSK Investigational Site

Neptune City, New Jersey, 07753, United States
GSK Investigational Site

Teaneck, New Jersey, 07666, United States
GSK Investigational Site

Hawthorne, New York, 10532, United States
GSK Investigational Site

New York, New York, 10016, United States
GSK Investigational Site

New York, New York, 10029, United States
GSK Investigational Site

New York, New York, 10065, United States
GSK Investigational Site

Rochester, New York, 14620-4159, United States
GSK Investigational Site

Stony Brook, New York, 11794, United States
GSK Investigational Site

Syracuse, New York, 13210, United States
GSK Investigational Site

Charlotte, North Carolina, 28204, United States
GSK Investigational Site

Canton, Ohio, 44710, United States
GSK Investigational Site

Cincinnati, Ohio, 45219, United States
GSK Investigational Site

Oklahoma City, Oklahoma, 73104, United States
GSK Investigational Site

Eugene, Oregon, 97401, United States
GSK Investigational Site

Portland, Oregon, 97227, United States
GSK Investigational Site

Paoli, Pennsylvania, 19301, United States
GSK Investigational Site

Philadelphia, Pennsylvania, 19111, United States
GSK Investigational Site

Pittsburgh, Pennsylvania, 15224, United States
GSK Investigational Site

Pittsburgh, Pennsylvania, 15232, United States
GSK Investigational Site

Willow Grove, Pennsylvania, 19001-3788, United States
GSK Investigational Site

Wynnewood, Pennsylvania, 19096, United States
GSK Investigational Site

Providence, Rhode Island, 02905, United States
GSK Investigational Site

Charleston, South Carolina, 29425, United States
GSK Investigational Site

Sioux Falls, South Dakota, 57105, United States
GSK Investigational Site

Knoxville, Tennessee, 37920, United States
GSK Investigational Site

Nashville, Tennessee, 37203, United States
GSK Investigational Site

Nashville, Tennessee, 37205, United States
GSK Investigational Site

Austin, Texas, 78731, United States
GSK Investigational Site

Dallas, Texas, 75246, United States
GSK Investigational Site

Fort Worth, Texas, 76104, United States
GSK Investigational Site

Houston, Texas, 77030, United States
GSK Investigational Site

San Antonio, Texas, 78240, United States
GSK Investigational Site

The Woodlands, Texas, 77380, United States
GSK Investigational Site

Tyler, Texas, 75702, United States
GSK Investigational Site

Ogden, Utah, 84405, United States
GSK Investigational Site

Charlottesville, Virginia, 22903, United States
GSK Investigational Site

Norfolk, Virginia, 23502, United States
GSK Investigational Site

Kennewick, Washington, 99336, United States
GSK Investigational Site

Seattle, Washington, 98104, United States
GSK Investigational Site

Seattle, Washington, 98109, United States
GSK Investigational Site

Minsk, 223040, Belarus
GSK Investigational Site

Brasschaat, 2930, Belgium
GSK Investigational Site

Bruges, 8000, Belgium
GSK Investigational Site

Vancouver, British Columbia, V5Z 4E6, Canada
GSK Investigational Site

London, Ontario, N6A 4L6, Canada
GSK Investigational Site

Toronto, Ontario, M4N 3M5, Canada
GSK Investigational Site

Montreal, Quebec, H2X 3E4, Canada
GSK Investigational Site

Montreal, Quebec, H4A 3J1, Canada
GSK Investigational Site

Sherbrooke, Quebec, J1H 5N4, Canada
GSK Investigational Site

Windsor, 1000, Canada
GSK Investigational Site

Prague, 128 51, Czechia
GSK Investigational Site

Prague, 180 81, Czechia
GSK Investigational Site

Copenhagen, DK- 2100, Denmark
GSK Investigational Site

Herlev, 2730, Denmark
GSK Investigational Site

Roskilde, 4000, Denmark
GSK Investigational Site

Helsinki, 00029, Finland
GSK Investigational Site

Kuopio, 70210, Finland
GSK Investigational Site

Tampere, 33520, Finland
GSK Investigational Site

Turku, 20520, Finland
GSK Investigational Site

Angers, 49055, France
GSK Investigational Site

Avignon, 84918, France
GSK Investigational Site

Besançon, 25030, France
GSK Investigational Site

Bordeaux, 33000, France
GSK Investigational Site

Bron, 69495, France
GSK Investigational Site

Caen, 14000, France
GSK Investigational Site

Cholet, 69373, France
GSK Investigational Site

Clermont-Ferrand, 63011, France
GSK Investigational Site

Dijon, 21079, France
GSK Investigational Site

Grenoble, 38000, France
GSK Investigational Site

Grenoble, 38700, France
GSK Investigational Site

Le Mans, 72000, France
GSK Investigational Site

Lille, 59000, France
GSK Investigational Site

Lyon, 69008, France
GSK Investigational Site

Lyon, 69373, France
GSK Investigational Site

Lyon, 69495, France
GSK Investigational Site

Marseille, 13273, France
GSK Investigational Site

Montpellier, 34070, France
GSK Investigational Site

Montpellier, 34298, France
GSK Investigational Site

Nancy, 54100, France
GSK Investigational Site

Nantes, 44227, France
GSK Investigational Site

Nice, 06189, France
GSK Investigational Site

Nîmes, 30029, France
GSK Investigational Site

Paris, 75014, France
GSK Investigational Site

Paris, 75020, France
GSK Investigational Site

Paris, 75248, France
GSK Investigational Site

Paris, 75908, France
GSK Investigational Site

Paris, 75970, France
GSK Investigational Site

Pierre-Bénite, 69495, France
GSK Investigational Site

Plerin-sur-mer, 22190, France
GSK Investigational Site

Poitiers, 86021, France
GSK Investigational Site

Reims, 51056, France
GSK Investigational Site

Rennes, 35042, France
GSK Investigational Site

Saint-Cloud, 75248, France
GSK Investigational Site

Saint-Priest-en-Jarez, 42271, France
GSK Investigational Site

Strasbourg, 67091, France
GSK Investigational Site

Toulouse, 31059, France
GSK Investigational Site

Tours, 37044, France
GSK Investigational Site

Villejuif, 94805, France
GSK Investigational Site

Berlin, 13125, Germany
GSK Investigational Site

Hamburg, 22457, Germany
GSK Investigational Site

Kiel, 24103, Germany
GSK Investigational Site

Münster, 48149, Germany
GSK Investigational Site

Ravensburg, 88212, Germany
GSK Investigational Site

Wolfsburg, 38440, Germany
GSK Investigational Site

Athens, 115 28, Greece
GSK Investigational Site

Athens, 11528, Greece
GSK Investigational Site

Athens, 12462, Greece
GSK Investigational Site

Haidari - Athens, 12462, Greece
GSK Investigational Site

Marousi, 15123, Greece
GSK Investigational Site

Beersheba, 8410101, Israel
GSK Investigational Site

Haifa, 3109601, Israel
GSK Investigational Site

Haifa, 3436212, Israel
GSK Investigational Site

Holon, 5822012, Israel
GSK Investigational Site

Petah Tikva, 4941492, Israel
GSK Investigational Site

Rehovot, 76100, Israel
GSK Investigational Site

Bologna, 40138, Italy
GSK Investigational Site

Faenza, 48018, Italy
GSK Investigational Site

Lugo RA, 48018, Italy
GSK Investigational Site

Meldola FC, 47014, Italy
GSK Investigational Site

Naples, 80131, Italy
GSK Investigational Site

Amsterdam, 1081 HV, Netherlands
GSK Investigational Site

Groningen, 9700 RB, Netherlands
GSK Investigational Site

Maastricht, 6229 HX, Netherlands
GSK Investigational Site

Nijmegen, 6525 GA, Netherlands
GSK Investigational Site

Rotterdam, 3015 GD, Netherlands
GSK Investigational Site

Utrecht, 3584 CX, Netherlands
GSK Investigational Site

Kristiansand, 4632, Norway
GSK Investigational Site

Oslo, 0310, Norway
GSK Investigational Site

Tromsø, 9019, Norway
GSK Investigational Site

Olsztyn, 10-228, Poland
GSK Investigational Site

Szczecin, 70-111, Poland
GSK Investigational Site

Warsaw, 02-781, Poland
GSK Investigational Site

Bucharest, 022328, Romania
GSK Investigational Site

Cluj-Napoca, 400015, Romania
GSK Investigational Site

Cluj-Napoca, 400051, Romania
GSK Investigational Site

Constanța, 900591, Romania
GSK Investigational Site

Craiova, 200347, Romania
GSK Investigational Site

Timișoara, 300239, Romania
GSK Investigational Site

Ávila, 05071, Spain
GSK Investigational Site

Badalona, 08916, Spain
GSK Investigational Site

Barcelona, 08036, Spain
GSK Investigational Site

Girona, 17007, Spain
GSK Investigational Site

Jaén, 23007, Spain
GSK Investigational Site

Madrid, 28046, Spain
GSK Investigational Site

Madrid, 28702, Spain
GSK Investigational Site

Santiago de Compostela, 15706, Spain
GSK Investigational Site

Toledo, 45007, Spain
GSK Investigational Site

Valencia, 46010, Spain
GSK Investigational Site

Zaragoza, 50009, Spain
GSK Investigational Site

Chernihiv, 14029, Ukraine
GSK Investigational Site

Kharkiv, 61024, Ukraine
GSK Investigational Site

Lviv, 79031, Ukraine
GSK Investigational Site

Glasgow, G12 0YN, United Kingdom
GSK Investigational Site

Metropolitan Borough of Wirral, CH63 4JY, United Kingdom
GSK Investigational Site

Portsmouth, PO6 3LY, United Kingdom
GSK Investigational Site

Sutton, SM2 5PT, United Kingdom
GSK Investigational Site

Truro, TR1 3LJ, United Kingdom

Conditions

Explore the condition pages connected to this study.

OVARIAN NEOPLASMS OVARIAN, FALLOPIAN TUBE AND PRIMARY PERITONEAL CARCINOMA